Company intelligence / Profile preview

New Frontier Bio

Beverly, Massachusetts, United Statesnewfrontierbio.com ↗

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

New Frontier Bio has launched a skin health and supplement line based on proprietary combinations of natural compounds with data supporting benefits across mechanisms of human aging, including skin aging. The company leverages rigorous scientific principles to develop efficacious consumer products targeting cellular regeneration and longevity. Their first product line includes supplements and topical serums designed to support NAD+ production through precursor nutrients rather than direct NAD+ application.

Therapeutic areas: OtherDermatology
Modalities: Natural compoundsNutraceuticalsTopical products/supplements
Industry: Food & Nutrition

Beyond the preview

Go deeper on New Frontier Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Frontier Bio.

Explore the full profile